MSI Claw 8 AI+ Takes on Asus ROG Ally X: Revolutionary Gaming Performance at 17W

MSI’s New Claw 8 AI+ Handheld Gaming PC Surpasses Asus ROG Ally X at 17W

Get ready for the latest development in the handheld gaming PC scene! MSI’s upcoming Claw 8 AI+ has reportedly outperformed the Asus ROG Ally X in multiple games, according to recently released benchmarks.

The Verdict is In: MSI’s Claw 8 AI+ Outperforms ROG Ally X at 17W TDP

Wccftech, a leading tech publication, has highlighted the impressive performance of the MSI Claw 8 AI+, showcasing its capability to deliver 20% better performance than the Asus ROG Ally X at a 17W TDP. This is evident in popular titles like Metro 2033, where the Claw 8 AI+ maintains an impressive 94 frames per second at 1080p low graphics settings, while the ROG Ally X settles for 44 frames per second under the same conditions.

Get Your Hands on the MSI Claw 8 AI+ – Available Now!

Pre-orders are now open for the MSI Claw 8 AI+, priced at $899.99, featuring Intel’s Series 2 Ultra 7 258V processor, 8 GPU cores, and an 80Wh battery – the same specs as the ROG Ally X. The Claw 8 AI+ boasts a larger 8-inch 1200p VRR display, which sets it apart from the ROG Ally X’s 7-inch 1080p VRR screen.

UK and AU Pricing Unavailable – For Now

While the price conversion for other regions remains unclear, the MSRP of $899.99 roughly translates to £705 / AU$1,415. Keep an eye out for future updates on pricing and availability for these regions.

Check Out the Latest Benchmark Results: [Image]

What’s Next for Asus After the ROG Ally X?

As the competition heats up in the handheld gaming PC sphere, it’s natural to wonder what lies ahead for Asus after the ROG Ally X. While MS’s recent benchmark results are impressive, Asus has the opportunity to catch up with future updates, potentially including the rumored Z2 Extreme. We’ll be keeping a close eye on the latest developments in this thrilling space!

You Might Also Like…

Stay up-to-date with the latest tech news, reviews, and opinion pieces. Sign up for our newsletter to stay ahead of the curve: